Pediatric Drugs

Papers
(The median citation count of Pediatric Drugs is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Diagnosis of Serious Conditions Delayed in Association with Ondansetron Treatment for Vomiting in the Pediatric Emergency Department86
Pharmacogenetic Aspects of Drug Metabolizing Enzymes and Transporters in Pediatric Medicine: Study Progress, Clinical Practice and Future Perspectives73
Alirocumab: Pediatric First Approval60
Perioperative Indications for Gabapentinoids in Pediatrics: A Narrative Review51
Treatment Options for Alopecia Areata in Children and Adolescents51
Optimizing Drug Selection in Children with Multiple Sclerosis: What Do We Know and What Remains Unanswered?46
Managing Lupus Nephritis in Children and Adolescents44
Gentamicin Pharmacokinetics in Neonates Undergoing Therapeutic Hypothermia for Hypoxic Ischemic Encephalopathy39
Recent Advances in the Management of Seizures in Children37
Acknowledgement to Referees31
Guselkumab: Pediatric First Approval28
Prevalence and Temporal Trends of Attention Deficit Hyperactivity Disorder Medication Fills During Pregnancy and Breastfeeding in Denmark24
Puzolcabtagene Autoleucel: Pediatric First Approval24
Commercial Versus Compounded Preparations in Pediatric Ophthalmology23
Vedolizumab Versus Other Biologics and the Risk of Venous Thromboembolism in Patients with Pediatric-Onset Inflammatory Bowel Diseases: A Target Trial Emulation Study23
History and Current Status of Growth Hormone Treatment in Children23
Acute Phase Reaction After First Neridronate Infusion in Children with Osteogenesis Imperfecta: An Analysis Based on Questionnaire Data from 65 Patients22
A New Perspective on Drugs for Duchenne Muscular Dystrophy: Proposals for Better Respiratory Outcomes and Improved Regulatory Pathways21
Efficacy of Secukinumab Across Subgroups and Overall Safety in Pediatric Patients with Moderate to Severe Plaque Psoriasis: Week 52 Results from a Phase III Randomized Study21
Intranasal Analgesia in Preterm and Term Neonates19
Low-Dose Remifentanil in Preterm Cesarean Section with General Anesthesia: A Randomized Controlled Trial18
Authors’ Reply to Fatima Comment on “Cardioprotective Effect of Nigella sativa in Pediatric Patients with Type 1 Diabetes Mellitus: A Randomized Controlled Study”17
New Information on Old Medicinal Products: A Cross-Sectional Analysis of Guidance for Paediatric Use for Substances on the European Priority List of Off-Patent Medicinal Products17
Real-World Data on the Use of Sirolimus in Asian Children with Vascular Malformations16
Analysis of Risk Factors for Chloral Hydrate Sedative Failure with Initial Dose in Pediatric Patients: a Retrospective Analysis15
Improving Methylphenidate Titration in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): A Randomized Controlled Trial Using Placebo-Controlled Titration Implemented in Clinical Practice15
Impact of β-Blockers on the Risk of Low-Birth-Weight Infants in Women with Long QT Syndrome or Marfan Syndrome: A Single-Center Retrospective Study from 2008 to 2022 in a Tertiary Care Center14
Ewing Sarcoma Drug Therapy: Current Standard of Care and Emerging Agents14
Inotuzumab Ozogamicin: First Pediatric Approval14
Dose Rationale of Nasal Glucagon in Japanese Pediatric Patients with Diabetes Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation14
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management14
Pharmacokinetics and Safety of Endotracheal Lidocaine for Endotracheal Intubation in Critically Ill Children14
Pediatric Treatment-Resistant Obsessive Compulsive Disorder: Treatment Options and Challenges14
Recent Developments in the Treatment of Pediatric Distal Renal Tubular Acidosis14
Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens–Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of14
Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant Patients14
Learning-Based Models for Predicting IVIG Resistance and Coronary Artery Lesions in Kawasaki Disease: A Review of Technical Aspects and Study Features14
Antipsychotic Medications for Delirium Treatment in the Pediatric Intensive Care Unit: A Systematic Review13
Diagnosis and Management of Non-Infectious Uveitis in Pediatric Patients13
Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children: Rationale and Progress to Date13
Oral Ibuprofen for the Treatment of PDA in Preterm Neonates: Urgent Need for a Safer Alternative to Hyperosmolar Formulations12
Long-Term Safety of Anti-Interleukin-1 Medications in Children with Rheumatic Diseases: a Systematic Review12
Current Treatment Modalities for Urea Cycle Disorders12
Levetiracetam Versus Fosphenytoin Infusions as Second-Line Treatment for Pediatric Status Epilepticus: A Multicenter Study Examining Effectiveness, Tolerability, and Ease of Use12
Doxecitine and Doxribtimine: First Approval12
An Update of Pharmacological Management in Children with Functional Constipation11
Emerging Treatments in Neonatal Fungal Infections: Progress and Prospects11
Impact of the Time to Initiation of Indomethacin or Ibuprofen on Patent Ductus Arteriosus Closure Rates11
Population Pharmacokinetics and Dose Optimization of Piperacillin in Infants and Children with Pneumonia11
Toward Optimal Treatment Outcomes in New-Onset Polyarticular-Course Juvenile Idiopathic Arthritis10
Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors10
Mechanistic Links Between Obesity and Airway Pathobiology Inform Therapies for Obesity-Related Asthma10
Optimizing Antifungal Therapy for Pediatric Tinea Capitis: A Narrative Review of Species-Specific Efficacy, Dosing Strategies, and Clinical Implications10
Off-Label Use of Anakinra in Inflammatory Conditions in Neonates and Infants Up to 3 Months of Age: A Case Series and a Review of the Literature10
Toxicity Spectrum of Anti-GD2 Immunotherapy: A Real-World Study Leveraging the US Food and Drug Administration Adverse Event Reporting System10
Targeted Treatments for Myasthenia Gravis in Children and Adolescents10
Adverse Event Profile of First-line Drugs for Treating Patent Ductus Arteriosus in Neonates: A Disproportionality Analysis Study of USFDA Adverse Event Reporting System10
Dosing and Discontinuation of Methylphenidate Medication in Relation to Weight Status in Children and Adolescents10
Comparison of Deep and Moderate Neuromuscular Blockade for Major Laparoscopic Surgery in Children: A Randomized Controlled Trial9
Insulin Glargine 300 U/mL Therapy in Children and Adolescents with Type 1 Diabetes9
Emerging Treatments for Childhood Interstitial Lung Disease9
Adverse Drug Reactions in Children with Congenital Heart Disease: A Scoping Review9
Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-center Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN8
Dual-Targeted Therapy in Pediatric Inflammatory Bowel Disease: A Comprehensive Review8
Fixed Dosing of Leuprolide Acetate, a GnRH Agonist, in Children with Central Precocious Puberty: A Population Pharmacokinetic Justification8
Prevalence and Perinatal Outcomes Following In Utero Exposure to Prehospital Emergency Methoxyflurane: A 17-Year Retrospective Cohort Study8
Copper Histidinate: Pediatric First Approval8
Effective Sirolimus Use in Prenatal and Postnatal Management of Symptomatic Extensive Congenital Capillary-Lymphatic-Venous Malformations (CLVMs): A Report of Two Cases8
Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A Systematic Review8
Neuroimaging as a Tool for Advancing Pediatric Psychopharmacology8
Phentermine/Topiramate: Pediatric First Approval8
Correction: European Society for Developmental Perinatal and Paediatric Pharmacology Congress, June 25 – 27, 2025, Nijmegen, The Netherlands8
Prescription Trends for Primary Headache in Children and Adolescents in China During 2019–2023: A Retrospective Study8
Safety and Efficacy of Ledipasvir/Sofosbuvir in the Treatment of Chronic Hepatitis C Virus Infection in Treatment-Naïve Children without and with Comorbidities8
Current and Emerging Therapies for Prevention and Treatment of Bronchopulmonary Dysplasia in Preterm Infants8
Advances in Management of Eosinophilic Esophagitis in Pediatrics7
Treatment Options for Juvenile Pityriasis Rubra Pilaris7
Macitentan in the Young—Mid-term Outcomes of Patients with Pulmonary Hypertensive Vascular Disease treated in a Pediatric Tertiary Care Center7
Dabigatran Etexilate: A Review in Pediatric Venous Thromboembolism7
The Effect of Alfentanil on Emergence Delirium Following General Anesthesia in Children: A Randomized Clinical Trial7
Cardioprotective Effect of Nigella sativa in Pediatric Patients with Type 1 Diabetes Mellitus: A Randomized Controlled Study7
Clozapine in Child and Adolescent Psychiatry7
Personalized Dosing of Medicines for Children: A Primer on Pediatric Pharmacometrics for Clinicians7
Optimising Paediatric HIV Treatment: Recent Developments and Future Directions7
Comparison of Different Doses of Oral and Ocular Propranolol for Retinopathy of Prematurity: A Network Meta-Analysis7
Juvenile Dermatomyositis: Updates in Pathogenesis and Biomarkers, Current Treatment, and Emerging Targeted Therapies6
Topical Management of Pediatric Psoriasis: A Review of New Developments and Existing Therapies6
Effect of Lactoferrin in Obese Children and Adolescents with Metabolic Dysfunction-Associated Steatotic Disease: A Randomized Controlled Study6
Treatment Options in Pediatric Behçet’s Disease6
Ganaxolone: A Review in Epileptic Seizures Associated with Cyclin-Dependent Kinase-Like 5 Deficiency Disorder6
Diagnosis and Management of Pediatric Neuropsychiatric Systemic Lupus Erythematosus: An Update6
Diagnosis and Management of Pediatric Chronic Hand Eczema: The PeDRA CACHES Survey6
What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review6
Macitentan: Pediatric First Approval6
A Multi-Center Evaluation of the Pharmacokinetics and Safety of Intravenous Ibuprofen in Infants 1–6 Months of Age6
Developing CAR T-Cell Therapies for Pediatric Solid Tumors6
Oral Lamivudine for Extended HIV Postnatal Prophylaxis6
Extrapolating Guselkumab Efficacy to Juvenile Psoriatic Arthritis from Adult Psoriatic Arthritis and Adult and Pediatric Psoriasis Data6
Enteral and Parenteral Treatment with Caffeine for Preterm Infants in the Delivery Room: A Randomised Trial5
Ferric Maltol: Pediatric First Approval5
Efficacy and Safety of Wound Catheter Infusion with Ropivacaine After Abdominal Surgery in Children Aged < 1 Year: A Randomized Controlled Trial5
Paediatric Drug Development in China: Current Status and Future Prospects5
Acknowledgement to Referees5
Medulloblastoma: Current Standard of Care and Future Treatment Opportunities5
Impact of Dexmedetomidine Infusion on Opioid and Benzodiazepine Doses in Ventilated Pediatric Patients in the Cardiac Intensive Care Unit5
How Consistent are Anti-Infective Drug Dosing Recommendations Across Three European Paediatric Formularies?5
Efficacy and Safety of Proactive Therapy with 2% Crisaborole Ointment in Children with Mild-to-Moderate Atopic Dermatitis: A Randomized Controlled Study5
Correction to: Viloxazine: Pediatric First Approval5
Antiretroviral Options and Treatment Decisions During Pregnancy5
Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis and Subcutaneous Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Extrapol5
A Review of Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Therapy for Gastroesophageal Reflux Disease in Neonates and Infants5
A Retrospective Review of Baclofen Treatment for Children with Rumination Syndrome at a Single Center5
Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study5
Authors’ Reply to Reed and Colleagues’ Comment on “Role of mTOR Inhibitors in Pediatric Liver Transplant Recipients: A Systematic Review”5
Population Pharmacokinetics of Adalimumab in Juvenile Idiopathic Arthritis Patients: A Retrospective Cohort Study Using Clinical Care Data4
The Future of Advanced Therapies for Pediatric Crohn’s Disease4
Pharmacotherapy for Cancer Treatment-Related Cardiac Dysfunction and Heart Failure in Childhood Cancer Survivors4
Ceftazidime/Avibactam for the Treatment of Infections in Children: A Case Series of Real-World Use4
Therapeutic Drug Monitoring of Antimicrobial Drugs in Children with Cancer: A New Tool for Personalized Medicine4
Therapeutic Drug Monitoring of Voriconazole in Critically Ill Pediatric Patients: A Single-Center Retrospective Study4
Big Data in the Assessment of Medication Safety in Pregnancy: Opportunities and Challenges4
Golimumab in Children with Chronic Recurrent Multifocal Osteomyelitis: A Case Series and Review of the Literature4
Ibrutinib: Pediatric First Approval4
Antibiotics for Paediatric Community-Acquired Pneumonia: What is the Optimal Course Duration?4
Neurological Adverse Effects of Antipsychotic Medication in Children and Young People4
Pediatric Drugs, Accelerated Approval, and Prospects for Reform4
Safety of Quinolones in Children: A Systematic Review and Meta-Analysis4
0.090521812438965